Indaptus Therapeutics Inc (INDP) Stock Price, Quote & News

Company Profile

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The com...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 427 2727

Website: indaptusrx.com

Address:

Three Columbus Circle, 15th Floor, New York, United States

LookinForGains Sep. 2 at 3:42 PM

$INDP seems like a ton of the little volume this stock trades is off-exchange or weirdly constructed in some way because ive watched 100k shares trade without the bid or ask changing.

0 · Reply

TwongStocks Sep. 1 at 11:35 AM

$INDP Replaced their prior June 2022 ATM agreement with HC Wainwright with a new $100M ATM https://www.sec.gov/ix?doc=/Archives/edgar/data/1857044/000149315226040926/form8-k.htm

0 · Reply

ShangVXO Aug. 27 at 9:06 AM

Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $MOBX / $INDP entry looks good

0 · Reply

lcrowI Aug. 27 at 9:05 AM

$INDP time

0 · Reply

LookinForGains Aug. 24 at 3:17 PM

$INDP damnt

0 · Reply

Alpha_Bull35 Aug. 23 at 4:25 PM

$INDP Technical structure is shifting rapidly and While it remains a highly speculative clinical-stage biotech play, the current price action suggests a high-probability asymmetric setup in favor of the bulls. 📊🐂🚀

1 · Reply

LookinForGains Aug. 21 at 2:24 PM

$INDP really thought this was going to run for a second day. Oh well

0 · Reply